CLOROX CO /DE/

CLX 10-Q · Q3 2026

CLX Q3 2026 request

Playground key active
Request URL /api/financials?ticker=CLX&year=2026&quarter=3
waiting 0 ms
Pick an endpoint and run the request.
curl

Income Statement

Income Statement
Metric Q3 2026 Q3 2025 YoY
Revenue 1,670 1,668 +0.1%
Show Business Segments breakouts
Health and Wellness · Operating Segments 629 630 -0.2%
Household · Operating Segments 482 469 +2.8%
International · Operating Segments 285 263 +8.4%
Lifestyle · Operating Segments 277 306 -9.5%
Show Consolidation Items breakouts
Corporate Non Segment -3
Operating Segments 1,673 1,668 +0.3%
Cost of Revenue 948 924 +2.6%
Show Business Segments breakouts
Health and Wellness · Operating Segments 319 305 +4.6%
Household · Operating Segments 316 308 +2.6%
International · Operating Segments 177 162 +9.3%
Lifestyle · Operating Segments 146 154 -5.2%
Gross Profit 722 744 -3.0%
Selling, General & Administrative 229 267 -14.2%
Advertising Expense 177 207 -14.5%
Research & Development 27 27 0.0%
Interest Expense 27 23 +17.4%
Other Expense Income Net 6 -34 +117.6%
Income Before Taxes 256 254 +0.8%
Income Tax Expense (Benefit) 65 63 +3.2%
Net Income 191 191 0.0%
Show Equity Components breakouts
Noncontrolling Interest 4 5 -20.0%
Retained Earnings 187 186 +0.5%
Net Income Loss Attributable To Noncontrolling Interest 4 5 -20.0%
Net Income 187 186 +0.5%
EPS (Basic) 1.54 1.51 +2.0%
EPS (Diluted) 1.54 1.5 +2.7%
Wtd Avg Shares (Basic) 121,363 123,367 -1.6%
Wtd Avg Shares (Diluted) 121,787 124,066 -1.8%
Comprehensive Income 194 191 +1.6%
Foreign Currency Transaction Gain Loss Before Tax 2 -1 +300.0%
Gain Loss On Investments 3 2 +50.0%

Balance Sheet

Balance Sheet
Metric Q3 2026 Q3 2025 YoY
Current Assets
Cash & Cash Equivalents 1,187
Show Fair Value Hierarchy breakouts
Fair Value Inputs Level1 · Money Market Funds 715
Fair Value Inputs Level2 · Bank Time Deposits 332
Receivables Net Current 671 597 +12.4%
Inventory 588
Prepaid Expenses & Other Current Assets 205 132 +55.3%
Total Current Assets 2,651 1,590 +66.7%
Non-Current Assets
Property, Plant & Equipment 1,235 1,245 -0.8%
Operating Lease Right-of-Use Assets 355 349 +1.7%
Goodwill 1,229 1,222 +0.6%
Other Non-Current Assets 415 537 -22.7%
Total Assets 6,436
Show Business Segments breakouts
Health and Wellness · Operating Segments 1,198
Household · Operating Segments 1,085
International · Operating Segments 1,306
Lifestyle · Operating Segments 1,098
Show Consolidation Items breakouts
Corporate Non Segment 1,749
Show Fair Value By Measurement Basis breakouts
Carrying Reported Amount Fair Value Disclosure 1,218
Other Assets
Trademarks Net 502 501 +0.2%
Other Intangible Assets Net 49 68 -27.9%
Current Liabilities
Commercial Paper 1,591
Show Fair Value Hierarchy breakouts
Fair Value Inputs Level2 · Carrying Reported Amount Fair Value Disclosure 1,591
Operating Lease Liability Current 85 85 0.0%
Accounts Payable And Accrued Liabilities Current 1,479 2,016 -26.6%
Total Current Liabilities 3,155 2,155 +46.4%
Non-Current Liabilities
Long-Term Debt 2,487 2,483 +0.2%
Operating Lease Liabilities 323 322 +0.3%
Other Non-Current Liabilities 356 341 +4.4%
Deferred Tax Liabilities 23 21 +9.5%
Total Liabilities 6,344
Show Fair Value By Measurement Basis breakouts
Carrying Reported Amount Fair Value Disclosure 4,078
Long-Term Debt (Q)
Show Fair Value Hierarchy breakouts
Fair Value Inputs Level2 · Carrying Reported Amount Fair Value Disclosure 2,487
Stockholders' Equity
Common Stock 131 131 0.0%
Additional Paid In Capital Common Stock 1,315 1,304 +0.8%
Retained Earnings 223 99 +125.3%
Treasury Stock Common Value -1,584
Accumulated Other Comprehensive Income -152 -176 +13.6%
Total Stockholders' Equity -67
Minority Interest 159 163 -2.5%
Stockholders Equity Including Portion Attributable To Noncontrolling Interest 92 190 -51.6%
Show Equity Components breakouts
Accumulated Defined Benefit Plans Adjustment -2 -2 0.0%
Accumulated Gain Loss Net Cash Flow Hedge Parent 80 78 +2.6%
Accumulated Other Comprehensive Income -152 -176 +13.6%
Accumulated Translation Adjustment -230 -252 +8.7%
Additional Paid In Capital 1,315 1,304 +0.8%
Common Stock 131 131 0.0%
Noncontrolling Interest 159 163 -2.5%
Retained Earnings 223 99 +125.3%
Treasury Stock Common -1,584 -1,331 -19.0%
Total Liabilities & Equity 6,436 5,512 +16.8%

Cash Flow Statement

Cash Flow Statement
Metric YTD Q3 2026 YTD Q3 2025 YoY
Operating Activities
Depreciation & Amortization 169 162 +4.3%
Show Business Segments breakouts
Health and Wellness · Operating Segments 44 42 +4.8%
Household · Operating Segments 63 58 +8.6%
International · Operating Segments 32 31 +3.2%
Lifestyle · Operating Segments 20 18 +11.1%
Show Consolidation Items breakouts
Corporate Non Segment 10 13 -23.1%
Stock-Based Compensation 49 64 -23.4%
Show Business Segments breakouts
Health and Wellness · Operating Segments 12 12 0.0%
Household · Operating Segments 8 9 -11.1%
International · Operating Segments 4 5 -20.0%
Lifestyle · Operating Segments 6 6 0.0%
Show Consolidation Items breakouts
Corporate Non Segment 19 32 -40.6%
Deferred Income Taxes 135 -16 +943.8%
Payment For Venture Agreement Termination -476
Other Non-Cash Items -18 -9 -100.0%
Increase Decrease In Receivables 158 71 +122.5%
Change in Inventory -64 -54 -18.5%
Change in Prepaid & Other Assets -14 -28 +50.0%
Increase Decrease In Accounts Payable And Accrued Liabilities -12 -87 +86.2%
Operating Lease Right Of Use Asset And Liability Net -5 1 -600.0%
Increase Decrease In Income Taxes Payable Net Of Income Taxes Receivable -74 -17 -335.3%
Net Cash from Operations 282 687 -59.0%
Investing Activities
Capital Expenditures -121 -145 +16.6%
Other Investing Activities 1 -1 +200.0%
Net Cash from Investing -120 -18 -566.7%
Financing Activities
Proceeds From Repayments Of Short Term Debt 1,581 50 +3062.0%
Share Repurchases -256 -257 +0.4%
Payments Of Dividends Common Stock -452 -452 0.0%
Issuance Of Common Stock For Employee Stock Plans And Other -16 30 -153.3%
Net Cash from Financing 857 -645 +232.9%
Other Cash Flow
Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents -2 -2 0.0%
Net Change in Cash 1,017 22 +4522.7%
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents 1,187 229 +418.3%

Values in millions USD. Source: SEC EDGAR 10-Q filing.

This table is rendered from the same JSON returned by /api/financials.

Get API Key